An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)
This protocol will study an investigational drug treatment plan against standard therapy in the prevention of chemotherapy-induced nausea and vomiting in patients diagnosed with breast cancer who are to be treated with up to 4 cycles of non-cisplatin moderately emetogenic chemotherapy.
Nausea|Vomiting|Breast Neoplasms
DRUG: MK0869, aprepitant / Duration of Treatment: 3 days|DRUG: Comparator: ondansetron / Duration of Treatment: 3 days
Emesis and use of rescue medication|Safety and tolerability
Quality of life
This protocol will study an investigational drug treatment plan against standard therapy in the prevention of chemotherapy-induced nausea and vomiting in patients diagnosed with breast cancer who are to be treated with up to 4 cycles of non-cisplatin moderately emetogenic chemotherapy.